S. Basci Et Al. , "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers," INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1, pp.135-139, 2022
Basci, S. Et Al. 2022. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1 , 135-139.
Basci, S., Ata, N., Altuntas, F., Yigenoglu, T. N., Dal, M. S., Korkmaz, S., ... Namdaroglu, S.(2022). Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1, 135-139.
Basci, Semih Et Al. "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers," INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1, 135-139, 2022
Basci, Semih Et Al. "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers." INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1, pp.135-139, 2022
Basci, S. Et Al. (2022) . "Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers." INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1, pp.135-139.
@article{article, author={Semih Basci Et Al. }, title={Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers}, journal={INTERNAL AND EMERGENCY MEDICINE}, year=2022, pages={135-139} }